vs

Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and Regional Management Corp. (RM). Click either name above to swap in a different company.

Regional Management Corp. is the larger business by last-quarter revenue ($167.3M vs $164.7M, roughly 1.0× PTC THERAPEUTICS, INC.). Regional Management Corp. runs the higher net margin — 6.8% vs -82.0%, a 88.8% gap on every dollar of revenue. On growth, Regional Management Corp. posted the faster year-over-year revenue change (9.4% vs -22.7%). Over the past eight quarters, Regional Management Corp.'s revenue compounded faster (8.2% CAGR vs -11.5%).

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

Millennium Management LLC is an investment management firm with a multistrategy hedge fund offering. It is one of the world's largest alternative asset management firms with $83.4 billion assets under management as of January 2026. The firm operates in America, Europe and Asia. As of 2022, Millennium had posted the fourth highest net gains of any hedge fund since its inception in 1989.

PTCT vs RM — Head-to-Head

Bigger by revenue
RM
RM
1.0× larger
RM
$167.3M
$164.7M
PTCT
Growing faster (revenue YoY)
RM
RM
+32.1% gap
RM
9.4%
-22.7%
PTCT
Higher net margin
RM
RM
88.8% more per $
RM
6.8%
-82.0%
PTCT
Faster 2-yr revenue CAGR
RM
RM
Annualised
RM
8.2%
-11.5%
PTCT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
PTCT
PTCT
RM
RM
Revenue
$164.7M
$167.3M
Net Profit
$-135.0M
$11.4M
Gross Margin
Operating Margin
-43.3%
Net Margin
-82.0%
6.8%
Revenue YoY
-22.7%
9.4%
Net Profit YoY
-104.8%
62.7%
EPS (diluted)
$-1.63
$1.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PTCT
PTCT
RM
RM
Q1 26
$167.3M
Q4 25
$164.7M
$169.7M
Q3 25
$211.0M
$165.5M
Q2 25
$178.9M
$157.4M
Q1 25
$1.2B
$153.0M
Q4 24
$213.2M
$154.8M
Q3 24
$196.8M
$146.3M
Q2 24
$186.7M
$143.0M
Net Profit
PTCT
PTCT
RM
RM
Q1 26
$11.4M
Q4 25
$-135.0M
$12.9M
Q3 25
$15.9M
$14.4M
Q2 25
$-64.8M
$10.1M
Q1 25
$866.6M
$7.0M
Q4 24
$-65.9M
$9.9M
Q3 24
$-106.7M
$7.7M
Q2 24
$-99.2M
$8.4M
Operating Margin
PTCT
PTCT
RM
RM
Q1 26
Q4 25
-43.3%
9.5%
Q3 25
1.4%
11.5%
Q2 25
-19.5%
8.6%
Q1 25
82.5%
6.0%
Q4 24
-76.2%
8.2%
Q3 24
-27.7%
6.9%
Q2 24
-21.5%
7.8%
Net Margin
PTCT
PTCT
RM
RM
Q1 26
6.8%
Q4 25
-82.0%
7.6%
Q3 25
7.5%
8.7%
Q2 25
-36.3%
6.4%
Q1 25
73.7%
4.6%
Q4 24
-30.9%
6.4%
Q3 24
-54.2%
5.2%
Q2 24
-53.1%
5.9%
EPS (diluted)
PTCT
PTCT
RM
RM
Q1 26
$1.18
Q4 25
$-1.63
$1.30
Q3 25
$0.20
$1.42
Q2 25
$-0.83
$1.03
Q1 25
$10.04
$0.70
Q4 24
$-0.85
$0.96
Q3 24
$-1.39
$0.76
Q2 24
$-1.29
$0.86

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PTCT
PTCT
RM
RM
Cash + ST InvestmentsLiquidity on hand
$1.9B
Total DebtLower is stronger
Stockholders' EquityBook value
$-205.3M
$375.8M
Total Assets
$2.9B
$2.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PTCT
PTCT
RM
RM
Q1 26
Q4 25
$1.9B
Q3 25
$1.7B
Q2 25
$2.0B
Q1 25
$2.0B
Q4 24
$1.1B
Q3 24
$1.0B
Q2 24
$1.1B
Total Debt
PTCT
PTCT
RM
RM
Q1 26
Q4 25
$1.6B
Q3 25
$1.6B
Q2 25
$1.5B
Q1 25
$1.5B
Q4 24
$1.5B
Q3 24
$1.4B
Q2 24
$1.4B
Stockholders' Equity
PTCT
PTCT
RM
RM
Q1 26
$375.8M
Q4 25
$-205.3M
$373.1M
Q3 25
$-155.8M
$371.9M
Q2 25
$-206.5M
$363.0M
Q1 25
$-185.8M
$357.9M
Q4 24
$-1.1B
$357.1M
Q3 24
$-1.1B
$352.9M
Q2 24
$-980.2M
$344.9M
Total Assets
PTCT
PTCT
RM
RM
Q1 26
$2.1B
Q4 25
$2.9B
$2.1B
Q3 25
$2.6B
$2.0B
Q2 25
$2.6B
$2.0B
Q1 25
$2.7B
$1.9B
Q4 24
$1.7B
$1.9B
Q3 24
$1.8B
$1.8B
Q2 24
$1.9B
$1.8B
Debt / Equity
PTCT
PTCT
RM
RM
Q1 26
Q4 25
4.40×
Q3 25
4.23×
Q2 25
4.14×
Q1 25
4.11×
Q4 24
4.12×
Q3 24
3.94×
Q2 24
3.98×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PTCT
PTCT
RM
RM
Operating Cash FlowLast quarter
$-34.3M
Free Cash FlowOCF − Capex
$-36.6M
FCF MarginFCF / Revenue
-22.3%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$702.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PTCT
PTCT
RM
RM
Q1 26
Q4 25
$-34.3M
$309.1M
Q3 25
$-66.3M
$86.7M
Q2 25
$-58.3M
$78.7M
Q1 25
$870.1M
$63.7M
Q4 24
$-30.0M
$268.9M
Q3 24
$-77.0M
$75.1M
Q2 24
$-71.5M
$71.5M
Free Cash Flow
PTCT
PTCT
RM
RM
Q1 26
Q4 25
$-36.6M
$304.3M
Q3 25
$-69.7M
$85.7M
Q2 25
$-59.6M
$77.6M
Q1 25
$868.4M
$62.4M
Q4 24
$-33.8M
$263.9M
Q3 24
$-77.5M
$73.8M
Q2 24
$-78.8M
$70.3M
FCF Margin
PTCT
PTCT
RM
RM
Q1 26
Q4 25
-22.3%
179.3%
Q3 25
-33.1%
51.8%
Q2 25
-33.3%
49.3%
Q1 25
73.8%
40.8%
Q4 24
-15.8%
170.4%
Q3 24
-39.4%
50.4%
Q2 24
-42.2%
49.1%
Capex Intensity
PTCT
PTCT
RM
RM
Q1 26
Q4 25
1.4%
2.8%
Q3 25
1.6%
0.6%
Q2 25
0.7%
0.6%
Q1 25
0.1%
0.8%
Q4 24
1.8%
3.3%
Q3 24
0.3%
0.9%
Q2 24
4.0%
0.8%
Cash Conversion
PTCT
PTCT
RM
RM
Q1 26
Q4 25
23.94×
Q3 25
-4.17×
6.04×
Q2 25
7.76×
Q1 25
1.00×
9.09×
Q4 24
27.13×
Q3 24
9.80×
Q2 24
8.47×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons